Comparative effectiveness of teclistamab vs real-world physician's choice of therapy in the LocoMMotion and MoMMent studies for patients with triple-class exposed relapsed/refractory multiple myeloma

Clinical Lymphoma, Myeloma & Leukemia(2023)

引用 0|浏览5
暂无评分
关键词
multiple myeloma,teclistamab,locommotion,real-world,triple-class
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要